English
español
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10261/56862
Share/Impact:
Statistics |
![]() ![]() ![]() |
|
|
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |||
|
Title: | Effect of aggregation state on the toxicity of different amphotericin B preparations |
Authors: | Espada, Raquel; Valdespina, Suriñe.; Alfonso, Carlos ![]() ![]() |
Keywords: | Amphotericin B Hemolysis Toxicity Aggregation Size |
Issue Date: | Sep-2008 |
Publisher: | Elsevier |
Citation: | International Journal of Pharmaceutics 361(1-2):64-69(2008) |
Abstract: | The aim of this work was to study the effect of aggregation of amphotericin B (AMB) in their toxicity. The aggregation of AMB depends on different formulation factors such as pH and excipients, therefore three formulations with different AMB aggregation states were prepared: a monomeric form (M-AMB), a dimeric form (D-AMB) and a poly-aggregated form (P-AMB). The predominant aggregation state of each AMB formulation was characterized by spectrophotometry and their size by dynamic laser light scattering. Toxicity was evaluated by lethality in mice and hemolysis test from human erythrocytes and the experimental AMB formulations were compared with reference formulations of AmBisome®, Fungizone® and heated Fungizone®. The less toxic aggregation form of AMB was the poly-aggregated one which was similar to AmBisome®. Moreover, the P-AMB and heated Fungizone® were centrifuged to isolate different size fractions. The toxicity of these two heterogeneous formulations was related to their size, so the smaller the aggregation size fraction the higher the toxicity determined by hemolysis. It can be concluded that the aggregation state of AMB and their size affects critically the toxicity of AMB. The low toxic P-AMB formulations contain a different poly-aggregated state to that of AmBisome®, heated Fungizone® and the other studied AMB aggregation states |
Description: | 6 páginas, 6 figuras, 2 tablas -- PAGS nros. 64-69 |
Publisher version (URL): | http://dx.doi.org/10.1016/j.ijpharm.2008.05.013 |
URI: | http://hdl.handle.net/10261/56862 |
DOI: | 10.1016/j.ijpharm.2008.05.013 |
ISSN: | 0378-5173 |
Appears in Collections: | (CIB) Artículos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
restringido.pdf | 21,67 kB | Adobe PDF | ![]() View/Open |
Show full item record
Review this work
Review this work
Related articles:
WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.